Science 37 taps NuvoAir to enable remote collection of lung health endpoints

By Nick Taylor

- Last updated on GMT

© Who_I_am / Getty Images
© Who_I_am / Getty Images

Related tags lung health respiratory health Remote monitoring

Science 37 has partnered with NuvoAir to incorporate connected devices for the remote collection of respiratory endpoints data into clinical trial designs.

NuvoAir has developed a digital respiratory care platform that features a suite of connected devices, including a CE marked and Food and Drug Administration cleared Bluetooth spirometer that enables patients to measure their lung health at home. The suite also includes a sensor that attaches to inhalers to track when and how patients take medications, an app that counts nightly coughs and more.

The platform, which also features an integrated patient app, clinician software and a wrap-around clinical service, has the potential to facilitate the remote collection of data for clinical trials. Rather than travel to a trial site to have their lung function assessed, patients could use the connected spirometer to capture data points such as the amount of air they can force from their lungs in one second.

NuvoAir’s potential to shift data collection from sites to the home aligns it with the focus of Science 37, the provider of an operating system designed to enable hybrid and decentralized clinical trials.

Science 37 has now secured the chance to incorporate NuvoAir’s remote spirometry capabilities into its clinical trials, enabling it to offer an expanded range of options to sponsors that want to capture data in respiratory studies remotely. 

In previous respiratory studies, we have used spirometry equipment and nurse training that replicates the equipment and training being used at brick-and-mortar sites. The partnership with NuvoAir affords us the opportunity to explore the use of additional connected respiratory devices that will provide more operational choices to our patients and pharma partners​,” said a spokesperson for Science 37.

The NuvoAir technology will slot into a portfolio that helped Science 37 generate sales of $19.3m in the second quarter, up 54% compared to the same period in 2021. However, net bookings were down, a trend the firm attributed to “a strategic shift in sales strategy to focus on larger studies, which generally have a longer bookings conversion timeline​,” and it made another loss as it invested in the business.

Related news

Related products

show more

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Validate clinical study data with Formedix CORE

Validate clinical study data with Formedix CORE

Content provided by Formedix | 19-Jun-2023 | White Paper

In April 2023 at the CDISC Europe Interchange, we launched Formedix CORE, the first free-to-use, downloadable application encompassing the CDISC Open Rules...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

Related suppliers

Follow us


View more